The FDA has granted marketing authorization for 20 Zyn nicotine pouch products after an extensive scientific review, marking a historic step as the first approval for nicotine pouches in the US market. Federal health officials emphasize the potential of these products to assist adult smokers in reducing cigarette use or quitting altogether, claiming that the public health benefits outweigh the associated risks. Meanwhile, concerns are raised regarding the rise in usage among younger individuals, positioning nicotine pouches as a persistent trend that might lead to health challenges.